Premium
Evidence for DNA Synthesis in Pneumocystis carinii Trophozoites Treated with the β‐1,3‐Glucan Synthesis Inhibitor Pneumocandin L‐693,989
Author(s) -
WYDER MICHAEL A.,
JOHNSTON LAURA Q.,
KANESHIRO EDNA S.
Publication year - 2010
Publication title -
journal of eukaryotic microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.067
H-Index - 77
eISSN - 1550-7408
pISSN - 1066-5234
DOI - 10.1111/j.1550-7408.2010.00502.x
Subject(s) - pneumocystis carinii , dapi , biology , dna synthesis , cytokinesis , dna , microbiology and biotechnology , dna replication , thymidine , glucan , virology , cell division , biochemistry , cell , genetics , staining , human immunodeficiency virus (hiv) , pneumocystis jirovecii
. Pneumocandins inhibit β‐1,3‐glucan synthesis preventing the development of Pneumocystis cysts that are absent from the lungs of treated rats. To determine whether treated trophozoites are capable of DNA replication, cytochemical analyses were performed on 4′,6‐diamidino‐2‐phenylindole (DAPI)‐ and DB181‐stained Pneumocystis carinii isolated from pneumocandin L‐693‐989‐treated rats. Fluorescence intensities of trophozoite nuclei from drug‐treated rats were greater than those of untreated controls, suggesting that DNA replication was not inhibited but that cytokinesis and perhaps karyokinesis were blocked.